Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Factor I reference typing report.

S Nakamura1, H Nishimukai, A Sawaguchi

  • 1Department of Legal Medicine, Tokyo Women's Medical College, Japan.

Complement and Inflammation
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Calreticulin mutant mice develop essential thrombocythemia that is ameliorated by the JAK inhibitor ruxolitinib.

Leukemia·2016
Same author

Serum C4 levels in patients with systemic lupus erythematosus in remission.

Modern rheumatology·2014
Same author

Small molecules modulating biogenesis or processing of microRNAs with therapeutic potentials.

Current medicinal chemistry·2013
Same author

Diabetes impairs mobilization of mouse bone marrow-derived Lin(-)/VEGF-R2(+) progenitor cells.

Blood cells, molecules & diseases·2013
Same author

Biotribological properties at the stem-cement interface lubricated with different media.

Journal of the mechanical behavior of biomedical materials·2013
Same author

Inhibition of transforming growth factor beta-activated kinase 1 confers neuroprotection after traumatic brain injury in rats.

Neuroscience·2013
Same journal

Computer-assisted kinetic assay for quantification of total complement activity.

Complement and inflammation·1991
Same journal

HLA complement markers in Italian narcoleptic patients with special emphasis on BfF subtyping.

Complement and inflammation·1991
Same journal

Sarcoidosis and major histocompatibility complex genes with special emphasis on BF F subtypes.

Complement and inflammation·1991
Same journal

Clinical manifestations in humans of combined C7 and C4 deficiency associated with low levels of C2, C8, and C9.

Complement and inflammation·1991
Same journal

Biomedical polymers differ in their capacity to activate complement.

Complement and inflammation·1991
Same journal

Bibliography of complement research for 1989.

Complement and inflammation·1991
See all related articles

Reference typing for complement factor I (IF) identified new genetic variants. This study details the discovery and classification of these novel alleles, expanding our understanding of complement system genetics.

Area of Science:

  • Immunogenetics
  • Complement system biology
  • Protein variant analysis

Background:

  • Complement factor I (IF) plays a crucial role in regulating the complement cascade.
  • Accurate genetic typing of IF is essential for understanding its role in various immunological conditions.
  • Previous typing methods had limitations in resolving rare or novel variants.

Purpose of the Study:

  • To establish a reliable method for complement factor I (IF) reference typing.
  • To identify and characterize new genetic variants of IF.
  • To determine the allelic frequencies of common and rare IF alleles.

Main Methods:

  • Polyacrylamide gel isoelectric focusing (IEF) was employed for protein separation.
  • Electroblotting was used to transfer separated proteins onto a membrane.

Related Experiment Videos

  • Enzyme immunoassay (EIA) was utilized for specific detection and typing of IF variants.

    • Main Results:

    • The developed method successfully classified submitted samples into distinct IF types.
    • Three common and two previously undescribed rare variants of IF were identified.
    • The genetic control was attributed to two common alleles (IF*B and IF*A) and two new rare alleles (IF*A1 and IF*B1).

    Conclusions:

    • The combination of IEF, electroblotting, and EIA provides a robust method for complement factor I (IF) reference typing.
    • The discovery of new rare alleles (IF*A1, IF*B1) expands the known genetic diversity of IF.
    • This typing system enhances the ability to study the genetic basis of complement-related disorders.